FDA Authorizes First Point-of-Care Hepatitis C Test Validated by RADx Tech
“Our NIH-funded Atlanta Center for Microsystems Engineered Point-of-Care, has been proud to serve the country through the RADx Tech and ITAP programs,” says Wilbur A. Lam, MD, PhD, Associate Dean of Innovation at Emory and Principal Investigator over the RADx program at Emory, Georgia Tech, and Children’s. “RADx served as the validation center for this important hepatitis C work.” Lam also serves as Georgia CTSA Innovation Catalyst Director.